Effect of Dietary Soy Protein Supplement in Dyslipidemic South Indian Population: A Randomized, Double-Blind, Placebo Controlled, Parallel-Group Trial

Narayanan, Chidambaram; Sethupathy, S; Saravanan, Nadanam; Toda, Toshiya; Mori, Mari; Yamori, Yukio; Garg, Arun; Chockalingam, Arun

doi:10.4172/2167-1095.1000206

Cited by 2 publications

(1 citation statement)

References 27 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…e American Diabetes Association (ADA) has recommended to include 26-50 g of soy protein per day (in place of animal protein), 25-30 g soluble fibre per day, Omega-3 fatty acids, and antioxidants (vitamin E, vitamin C, and β-carotene) in daily diet for the prevention and treatment of CVD [15,16]. Studies on Asian Indians reported that soy supplementation in diet helps to manage blood glucose levels in both normal and overweight/obese patients with T2DM [17][18][19].…”

Section: Introductionmentioning

confidence: 99%

Effect of a High-Protein High-Fibre Nutritional Supplement on Lipid Profile in Overweight/Obese Adults with Type 2 Diabetes Mellitus: A 24-Week Randomized Controlled Trial

Bhoite

Anitha

Pratti

et al. 2021

Journal of Nutrition and Metabolism

View full text Add to dashboard Cite

Background. Foods rich in protein and dietary fibre could potentially improve lipid profile in overweight or obese diabetic patients with dyslipidemia and, thereby, mitigate their risk of cardiovascular disease (CVD). In this study, the effect of providing high-protein high-fibre (HPHF) nutritional supplement in addition to standard care of type 2 diabetes mellitus (T2DM) on lipid profile was evaluated. Methods. In this open-label, parallel-arm, prospective, randomized study, a total of 100 overweight/obese participants with T2DM were randomized to either an intervention group (25 g HPHF nutritional supplement given twice daily along with a standard care of T2DM) or a control group (standard care of T2DM) for 24 weeks. Change from baseline in lipid parameters such as total cholesterol (TChol), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) was assessed between the intervention and control group at week 12 and week 24. Participant compliance was assessed using the dietary 24-hour recall. Statistical analysis was performed to assess the main effects on within- and between-group changes from baseline to end of 24 weeks. Results. Participants in the HPHF nutritional supplement group showed a statistically significant improvement in HDL-C levels by the end of 24 weeks ( p = 0.04 ) and a significant increase in protein and total dietary fibre intake ( p = 0.002 and p = 0.00 , respectively) compared to the control group. The TChol/HDL-C ratio was significantly lower ( p = 0.03 ) in the HPHF group from baseline to 24 weeks. Conclusion. Twice-daily consumption of a HPHF nutritional supplement significantly improved HDL-C levels. Inclusion of the HPHF supplement would be a useful effective aid for managing dyslipidemia in overweight/obese individuals with T2DM.

show abstract

Section: Introductionmentioning

confidence: 99%